Immunosuppression in the human tumor microenvironment
Friday, February 1, 2019
09:00 a.m.–06:00 p.m.
Salle des Guichets
Bip, Rue Royale 2–4
Brussels, Belgium
09:00 a.m. | Opening: Have we yet understood the key mechanisms to unleash the anti-tumor response? |
Tumor microenvironment: The innate immune system | |
09:30 a.m. | Human tumor-associated macrophage transcriptional landscape in solid tumors |
10:05 a.m. | NK cell activation and exhaustion: two sides of the same coin Thierry Walzer, Lyon, France |
10:40 a.m. | Coffee break |
11:20 a.m. | The diversity of cancer-related neutrophils. Their impact on the tumor microenvironment and cancer progression. Zvi Fridlander, Jerusalem, Israel |
Tumor microenvironment: T lymphocytes | |
11:55 a.m. | Targeting GARP on Tregs: a novel approach for the immunotherapy of cancer Sophie Lucas, Brussels, Belgium |
12:30 p.m. | Deciphering the immune landscape of the human cancer microenvironment Massimiliano Pagani, Milan, Italy |
01:05 p.m. | Lunch break |
Metabolism and glycosylation | |
02:30 p.m. | Metabolic interventions to enhance anti-tumor immune responses Roger Geiger, Bellinzona, Switzerland |
03:05 p.m. | Glycans as immune checkpoints for cancer immunotherapy Yvette van Kooyk, Amsterdam, Netherlands |
03:40 p.m. | Coffee break |
Dendritic cell and CAR T cell therapies | |
04:00 p.m. | Development of 21st century cancer vaccines Carl Figdor, Nijmegen, Netherlands |
04:35 p.m. | Dissecting mechanisms of tumor immune surveillance and immunotherapies at the single cell level Philippe Bousso, Paris, France |
05:10 p.m. | Moving CAR T cell therapy into solid tumors Gianpietro Dotti, Chapel Hill, North Carolina, USA |
05:45 p.m. | Closing/Farewell Tim Oliver Stolle (Miltenyi Biotec), Leiden, Netherlands |
06:00 p.m. | Celebration party |
Seems like you are coming from USA!
Do you want to visit our website in your country?